Development of a patient decision aid for the treatment of Osteoporosis among Filipino Postmenopausal women
https://doi.org/10.15605/jafes.035.01.15
- Author:
Ma. Carrissa Abigail Roxas
1
;
Cecilia Jimeno
1
,
2
;
Lia Palileo-Villanueva
3
;
Anna Angelica Macalalad-Josue
1
;
Mark Anthony Sandoval
1
;
Jose Alberto Fernandez
4
Author Information
1. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of the Philippines-Philippine General Hospital, Philippines
2. College of Medicine, University of the Philippines Manila, Philippines
3. College of Medicine, University of the Philippines Manila, Philippines
4. University of the Philippines Diliman, Quezon City, Philippines
- Publication Type:Journal Article
- Keywords:
Patient decision aid;
Shared decision-making
- MeSH:
Osteoporosis;
Therapeutics
- From:
Journal of the ASEAN Federation of Endocrine Societies
2020;35(1):93-101
- CountryPhilippines
- Language:English
-
Abstract:
Background:Guidelines for osteoporosis have provided recommendations on when to offer pharmacologic management for postmenopausal women, but do not specify which “best” medication to start. The choice of therapy depends on the efficacy, safety/tolerability of the drug and the patient’s profile and preferences. Patient decision aids (PtDA) are tools designed to facilitate shared decision-making (SDM) between the patient and health care provider for conditions where there are several available options, and the “best” choice is unclear. We aimed to develop a culturally acceptable patient decision aid on the treatment of osteoporosis among Filipino postmenopausal women at risk of osteoporotic fractures.
Methodology:A qualitative approach and an iterative process was employed in this study following the guidance of the International Patient Decision Aid Standards (IPDAS). Phase 1 (Needs Assessment) involved interviews with 8 physicians who are involved in the care of women with osteoporosis and focus group discussions with 19 postmenopausal women with osteoporosis who have received treatment. Phase 2 (PtDA Development) involved a systematic review of evidence and development of an initial prototype through several iterations with an expert panel. The final prototype was pilot tested in actual clinical encounters (Phase 3).
Results:The final PtDA consists of 6 laminated flashcards, which illustrate the different considerations that are important to patients when selecting an anti-osteoporosis treatment (efficacy, method, frequency of administration, side effects and cost), and a fracture worksheet to illustrate individualized effects of the treatments on the patient's fracture risk. These are accompanied by a clinician guide on how to use the PtDA during consultations, which includes information on non-pharmacologic management of osteoporosis. The PtDA was acceptable to physicians and patients.
Conclusion:With the integration of decisional needs assessment, clinical expertise, user preference and iterative revision testing, we were able to develop a culturally adapted PtDA on the treatment of osteoporosis among Filipino postmenopausal woman at risk of osteoporotic fractures for use during clinical encounters.
- Full text:693-Article Text-10033-1-10-20200530.pdf
